Faculty of Pharmaceutical Sciences, University of British Columbia , 2405 Wesbrook Mall, Vancouver, BC, Canada V6T 1Z3.
Mol Pharm. 2013 Aug 5;10(8):3203-12. doi: 10.1021/mp4002415. Epub 2013 Jun 24.
P-glycoprotein (Pgp, encoded by ABCB1, commonly known as MDR1), an ATP-dependent transporter with a broad range of hydrophobic drug substrates, has been associated with the in vitro intracellular transport of cholesterol; however, these findings have not been confirmed in vivo. In this manuscript we tested the contributions of Pgp to in vivo cholesterol homeostasis by comparing the cholesterol phenotype of wild type mice with mice lacking both murine isoforms of Pgp (Abcb1a(-/-)/1b(-/-)) by measuring cholesterol absorption, circulating cholesterol, and lipoprotein cholesterol profiles. The mice were fed diets containing normal or high levels of dietary fat (25% vs 45% kcal from fat) and cholesterol (0.02% vs 0.20% w/w) for 8 weeks to challenge their capacity to maintain homeostasis. There were no significant differences in cholesterol absorption, circulating cholesterol levels, and lipoprotein profiles between Pgp knockout and wild type mice fed matching diets. Compensatory shifts were observed in the activation of two key transcription factors involved in maintaining cholesterol balance, the Liver X Receptor and SREBP-2, which may have maintained the wild type phenotype in the knockout mice. Deletion of Pgp affected the molar composition of gallbladder bile, when the mice were fed diets containing high levels of dietary fat, cholesterol, or both. The mole fraction of bile salts was reduced in the gallbladder bile of Pgp knockout mice, while the mole fraction of cholesterol was increased. In this paper, we provide evidence that Pgp knockout mice maintain cholesterol homeostasis, even when challenged with high cholesterol diets. We suggest that the specific shifts in cholesterol regulatory networks identified in the jejunum and liver of the knockout mice may have compensated for the lack of Pgp. Our finding that Pgp knockout mice were unable to maintain gallbladder bile composition when challenged with high dietary fat and/or cholesterol compliments recent reports that Pgp may be a secondary bile salt export pump.
P-糖蛋白(Pgp,由 ABCB1 编码,通常称为 MDR1)是一种具有广泛疏水性药物底物的 ATP 依赖性转运蛋白,与胆固醇的细胞内转运有关;然而,这些发现尚未在体内得到证实。在本文中,我们通过比较野生型小鼠和缺乏两种鼠源 Pgp 同工型(Abcb1a(-/-)/1b(-/-))的小鼠的胆固醇表型,来测试 Pgp 对体内胆固醇稳态的贡献,方法是测量胆固醇吸收、循环胆固醇和脂蛋白胆固醇谱。这些小鼠在 8 周内分别喂食含有正常或高脂肪(25% vs 45%来自脂肪的卡路里)和高胆固醇(0.02% vs 0.20% w/w)的饮食,以挑战它们维持体内平衡的能力。在喂食匹配饮食的 Pgp 敲除和野生型小鼠之间,胆固醇吸收、循环胆固醇水平和脂蛋白谱没有显著差异。观察到两种参与维持胆固醇平衡的关键转录因子——肝 X 受体和 SREBP-2 的激活发生了代偿性变化,这可能使敲除小鼠保持了野生型表型。当喂食含有高脂肪、高胆固醇或两者的饮食时,Pgp 缺失会影响胆囊胆汁的摩尔组成。在 Pgp 敲除小鼠的胆囊胆汁中,胆汁盐的摩尔分数减少,而胆固醇的摩尔分数增加。本文提供了证据表明,即使在高胆固醇饮食的挑战下,Pgp 敲除小鼠也能维持胆固醇稳态。我们认为,在敲除小鼠的空肠和肝脏中鉴定出的胆固醇调节网络的特定变化可能补偿了 Pgp 的缺失。我们发现,当受到高脂肪和/或高胆固醇饮食的挑战时,Pgp 敲除小鼠无法维持胆囊胆汁的组成,这与最近的报道相补充,即 Pgp 可能是一种次要的胆汁盐输出泵。